CIPCarbone Farmasimplex up to 16.1.x CeliachiaRL Integration improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.0 | $0-$5k | 0.00+ |
Summary
A vulnerability, which was classified as critical, was found in CIPCarbone Farmasimplex up to 16.1.x. This issue affects some unknown processing of the component CeliachiaRL Integration. The manipulation results in improper authorization. This vulnerability is known as CVE-2026-123052. It is possible to launch the attack remotely. No exploit is available. You should upgrade the affected component.
Details
A vulnerability was found in CIPCarbone Farmasimplex up to 16.1.x. It has been classified as critical. Affected is some unknown functionality of the component CeliachiaRL Integration. The manipulation with an unknown input leads to a improper authorization vulnerability. CWE is classifying the issue as CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials across multiple customer installations. An attacker who obtains the credentials from one installation could reuse them against services associated with other installations, potentially leading to unauthorized access to sensitive information or modification of integration data.
The advisory is available at acn.gov.it. This vulnerability is traded as CVE-2026-123052 since 11/05/2026. The exploitability is told to be easy. It is possible to launch the attack remotely. The technical details are unknown and an exploit is not available. This vulnerability is assigned to T1548.002 by the MITRE ATT&CK project.
Upgrading to version 16.2.0 eliminates this vulnerability.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.0
VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: Farmasimplex 16.2.0
Timeline
11/05/2026 CVE reserved11/17/2026 Advisory disclosed
11/17/2026 VulDB entry created
11/17/2026 VulDB entry last update
Sources
Advisory: acn.gov.itStatus: Confirmed
CNA: ENISA
CVE: CVE-2026-123052 (🔒)
GCVE (CVE): GCVE-0-2026-123052
GCVE (VulDB): GCVE-100-438090
Entry
Created: 11/17/2026 15:56Changes: 11/17/2026 15:56 (67)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.